HeartFlow Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 643

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 29

HeartFlow General Information

Description

Developer of a cardiac diagnostic platform designed to transform the diagnosis and management of coronary artery diseases. The company's platform uses data from standard computerized tomography scans to create a personalized three-dimensional model of arteries and analyzes the impact of blockages on blood flow, enabling clinicians to treat patients with significant coronary artery disease while reducing unnecessary invasive testing.

Contact Information

Formerly Known As
Cardiovascular Simulation, HeartFlow Holding
Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • 331 East Evelyn Avenue
  • Mountain View, CA 94041
  • United States
+1 (650)
Primary Industry
Decision/Risk Analysis
Vertical(s)
Corporate Office
  • 331 East Evelyn Avenue
  • Mountain View, CA 94041
  • United States
+1 (650)

HeartFlow Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HeartFlow Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. IPO 19-Jan-2025 Announced Generating Revenue
14. Later Stage VC 11-Apr-2025 Completed Generating Revenue
13. Later Stage VC (Series F) 02-Mar-2023 Completed Generating Revenue
12. Reverse Merger 15-Jul-2021 Cancelled Generating Revenue
11. Later Stage VC 18-Dec-2019 Completed Generating Revenue
10. Secondary Transaction - Private 14-Jun-2019 Completed Generating Revenue
9. Later Stage VC (Series E) 13-Jun-2019 Completed Generating Revenue
8. Later Stage VC (Series E) 14-Feb-2018 Completed Generating Revenue
7. Later Stage VC (Series D) 10-May-2016 $100M $263M Completed Generating Revenue
6. Later Stage VC 01-Feb-2015 $35.9M $163M Completed Generating Revenue
To view HeartFlow’s complete valuation and funding history, request access »

HeartFlow Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E
Series D
Series C
Series B2
Series B1 1,954,846 $0.001000 $0.28 $3.55 $3.55 1x $3.55 3.16%
Series A 4,082,965 $0.001000 $0.03 $0.5 $0.5 1x $0.5 6.61%
To view HeartFlow’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

HeartFlow Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a cardiac diagnostic platform designed to transform the diagnosis and management of coronary artery disease
Decision/Risk Analysis
Mountain View, CA
643 As of 2025

Pessac, France
 

Denver, CO
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HeartFlow Competitors (22)

One of HeartFlow’s 22 competitors is inHEART, a Private Equity-Backed company based in Pessac, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
inHEART Private Equity-Backed Pessac, France
Cleerly Venture Capital-Backed Denver, CO
Vista.ai Venture Capital-Backed Palo Alto, CA
Arterys Formerly VC-backed San Francisco, CA
Advantis Medical Imaging Venture Capital-Backed Eindhoven, Netherlands
You’re viewing 5 of 22 competitors. Get the full list »

HeartFlow Patents

HeartFlow Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240387045-A1 Systems and methods for processing electronic images to quantify coronary microvascualar disease Pending 17-May-2023
US-20230169702-A1 Systems and methods for processing electronic images for physiology-compensated reconstruction Pending 29-Nov-2021
US-20230165544-A1 Systems and methods for processing electronic images using user inputs Pending 29-Nov-2021
US-20220359063-A1 Systems and methods for processing electronic images to determine a planar mapping Pending 05-May-2021
CA-3216802-A1 Systems and methods for processing electronic images to determine a planar mapping Pending 05-May-2021 G06T19/00
To view HeartFlow’s complete patent history, request access »

HeartFlow Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HeartFlow Investors (29)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fidelity Management & Research Company Asset Manager
3Spoke Capital Growth/Expansion Majority
Bain Capital Life Sciences Corporate Venture Capital Minority
Hayfin Capital Management Asset Manager Minority
Janus Henderson Investors Asset Manager Minority
You’re viewing 5 of 29 investors. Get the full list »

HeartFlow FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »